Quarterly report (Form 10-Q)
Johnson & Johnson 10-Q for Quarter ended Jun 28, 2026
Filing excerpt
Consolidated earnings before provision for taxes on income for the fiscal six months of 2026 was $12.7 billion representing 25.8% of sales as compared to $20.1 billion in the fiscal six months of 2025, representing 44.1% of sales.